Drug Trafficking, Organized Crime, and Violence in the Americas Today


Book Description

"An extensive overview of the drug trade in the Americas and its impact on politics, economics, and society throughout the region. . . . Highly recommended."--Choice "A first-rate update on the state of the long-fought hemispheric 'war on drugs.' It is particularly timely, as the perception that the war is lost and needs to be changed has never been stronger in Latin and North America."--Paul Gootenberg, author of Andean Cocaine: The Making of a Global Drug "A must-read volume for policy makers, concerned citizens, and students alike in the current search for new approaches to forty-year-old policies largely considered to have failed."--David Scott Palmer, coauthor of Power, Institutions, and Leadership in War and Peace "A very useful primer for anyone trying to keep up with the ever-evolving relationship between drug enforcement and drug trafficking."--Peter Andreas, author of Smuggler Nation: How Illicit Trade Made America In 1971, Richard Nixon declared a war on drugs. Despite foreign policy efforts and attempts to combat supply lines, the United States has been for decades, and remains today, the largest single consumer market for illicit drugs on the planet. This volume argues that the war on drugs has been ineffective at best and, at worst, has been highly detrimental to many countries. Leading experts in the fields of public health, political science, and national security analyze how U.S. policies have affected the internal dynamics of Mexico, Colombia, Bolivia, Peru, Brazil, Argentina, Central America, and the Caribbean islands. Together, they present a comprehensive overview of the major trends in drug trafficking and organized crime in the early twenty-first century. In addition, the editors and contributors identify emerging issues and propose several policy options to address them. This accessible and expansive volume provides a framework for understanding the limits and liabilities in the U.S.-championed war on drugs throughout the Americas.










Pain Management and the Opioid Epidemic


Book Description

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.










Current Catalog


Book Description

First multi-year cumulation covers six years: 1965-70.




Drug Money Laundering Control Efforts


Book Description